WikiDrug / Manufacturers / Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

1 published medicine associated with this manufacturer.

MedicineActive ingredientDosage formStrength
Bevacizumab Bevacizumab-vikg Injection 1.25 mg (0.05 mL of 25 mg/mL)